| CTRI Number |
CTRI/2025/10/096726 [Registered on: 31/10/2025] Trial Registered Prospectively |
| Last Modified On: |
30/10/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Behavioral |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Does use of brief intervention, a type of motivational interview technique to quit tobacco lead to better pain relief in patients with chronic pancreatitis and tobacco use as compared to standard of care |
|
Scientific Title of Study
|
Brief intervention for tobacco addiction in addition to standard of care for pain relief in chronic pancreatitis: A parallel group, superiority, randomized trial |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Anshuman Elhence |
| Designation |
Associate Professor |
| Affiliation |
Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| Address |
Department of Gastroenterology, SGPGI Lucknow.
Main hospital Building, C-block
Lucknow UTTAR PRADESH 226014 India |
| Phone |
08587935706 |
| Fax |
|
| Email |
anshu27790@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Anshuman Elhence |
| Designation |
Associate Professor |
| Affiliation |
Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| Address |
Department of Gastroenterology, SGPGI Lucknow.
Main hospital Building, C-block
Lucknow UTTAR PRADESH 226014 India |
| Phone |
08587935706 |
| Fax |
|
| Email |
anshu27790@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Anshuman Elhence |
| Designation |
Associate Professor |
| Affiliation |
Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| Address |
Department of Gastroenterology, SGPGI Lucknow.
Main hospital Building, C-block
Lucknow UTTAR PRADESH 226014 India |
| Phone |
08587935706 |
| Fax |
|
| Email |
anshu27790@gmail.com |
|
|
Source of Monetary or Material Support
|
| Indian Council of Medical Research (ICMR)
IIRPSG-2025-01-04457 |
|
|
Primary Sponsor
|
| Name |
Indian Council of Medical Research |
| Address |
Indian Council of Medical Research Ansari Nagar, New Delhi 110029 |
| Type of Sponsor |
Government funding agency |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Anshuman Elhence |
Sanjay Gandhi Post Graduate Institute of Medical Sciences |
Department of Gastroenterology, C-block, academic wing, Room no 3 Lucknow UTTAR PRADESH |
08587935706
anshu27790@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee SGPGI |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K860||Alcohol-induced chronic pancreatitis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Brief intervention |
Brief intervention, a non-pharmacological motivational interviewing approach shown to help quit tobacco will be administered by a trained psychiatrist with 5 years training. This will be done using 5 “A” and 5 “R” approach as described in National tobacco dependence treatment guidelines.This will be done during a 20-30 minutes face-to-face session and with follow up counselling done telephonically after 1 week. This will be in addition to standard of care. |
| Comparator Agent |
Standard of care arm. |
The standard of care arm will receive only routine physician advice for quitting tobacco and alcohol along with antioxidants and analgesics as per physician discretion which are part of standard of care of these patients. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
75.00 Year(s) |
| Gender |
Both |
| Details |
1.Chronic pancreatitis with active tobacco intake (more than 1 cigarette/bidi/pack of gutkha/khaini per day more than 6 months)
2. Age more than 18 years
3. Those who give informed consent
|
|
| ExclusionCriteria |
| Details |
1.Patients with chronic pancreatitis with no tobacco intake or less than 1 bidi/cigarette/pack of khaini/guthka per day)
2.Pancreatic cancer
3.Mass-forming chronic pancreatitis
4.Pre-diagnosed psychiatric comorbidities
5.Pregnancy
6.Patients with chronic pancreatitis and symptomatic peptic ulcer disease/biliary stricture or pseudocyst requiring drainage.
7.Patients with non-dilated pancreatic duct and stones filling the pancreatic duct till body-tail region.
|
|
|
Method of Generating Random Sequence
|
Adaptive randomization, such as minimization |
|
Method of Concealment
|
Centralized |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Difference in Izbicki pain score between the two intervention arms at 6 months |
Difference in Izbicki pain score between the two intervention arms at 6 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Proportion of patients with complete pain relief (Izbicki score less than 10) |
6 months |
| Proportion of patients with partial pain relief (Izbicki score more than 10 but more than 25% decline) |
6 months |
| Proportion of patients abstinent as per Russell standard |
6 months |
| Proportion of patients with self-reported abstinence |
6 months |
| Proportion of patients with more than 50% decline in tobacco intake |
6 months |
| Time to recidivism from the quit date |
follow up of six months |
|
|
Target Sample Size
|
Total Sample Size="66" Sample Size from India="66"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
30/11/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Rationale Brief intervention for tobacco cessation is a non-pharmacologic therapy for helping those addicted quit tobacco more effectively than just a usual advice from physician and is recommended form of counselling as per National Tobacco Control Program (NTCP) of India. Most guidelines strongly recommend tobacco cessation for pain relief in chronic pancreatitis (CP). Despite this the role of tobacco cessation in pain control in CP has not been explored prospectively. Novelty Addition of brief intervention to standard of care for pain management in patients with CP with active tobacco intake will not only provide better pain relief but also align with the NTCP goal of integrating tobacco cessation services with existing infrastructure in gastroenterology outpatient setting. Objectives: 1) Efficacy of brief intervention(I) for tobacco addiction in addition to standard of care(C) for pain relief (O) in patients with chronic pancreatitis and active tobacco intake (P).2)Efficacy of brief intervention for tobacco addiction in addition to standard of care for abstinence among patients with chronic pancreatitis and active tobacco intake. Methods Investigator-initiated parallel group, superiority-framework, randomized-controlled trial with an allocation ratio of 1:1. Intervention-arm A will receive brief intervention by a psychiatrist along with standard-of-care for pain relief in CP. Control-arm B will receive only standard-of-care of pain relief in CP which includes routine advice to quit tobacco. Expected outcomes Pain relief as assessed on Izbicki scale as well as tobacco abstinence rates will be assessed among the two groups. The results will help consolidate the NTCP goals. |